TrialThe Lancet. Oncology2013

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.

Gwenaelle Gravis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.